Evidence map›Paper›PMID 24034998›Full record

ReviewZhongguo fei ai za zhi = Chinese journal of lung cancer2013

[The prognostic value of micrometastasis in non-small cell lung cancer].

Yuanyuan Lei, Yilong Wu

Open access · greenAbstract readEnglish AbstractReview
In one paragraph

Review in Zhongguo fei ai za zhi = Chinese journal of lung cancer, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Yuanyuan LeiGuangdong Lung Cancer Institute, Guangdong Genral Hospital & Guangdong Academy of Medical Sciences, Guangzhou 510080, China;Southern Medical University, Guangzhou 510515, China.
Yilong Wu
Southern Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lung cancer ranks top in morbidity and mortality among the malignancies in China. Non-small cell lung cancer (NSCLC) accounts for about 80%-85% of all lung malignancies. The stage at diagnosis is the principal prognostic indicator, and accurate staging is essential for treatment decisions. After radical surgical resection in patients with stage I disease, the recurrence rate ranges from 25% to 30%. Patients with a poor outcome may have occult locoregional and/or distant metastasis before resection. In recent years, there are a lot of researches aimingat detecting micrometastasis and evaluating the prognostic value of it. This study reviewed the prognostic value of micrometastasis in lymph node, bone marrow, pleural cavity and peripheral blood.

Indexed as

Neoplasm MicrometastasisBone NeoplasmsCarcinoma, Non-Small-Cell LungHumansLymphatic MetastasisPrognosis

Identifiers

PMID24034998
PMCPMC6000635
OpenAlexW1596966867

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.